BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18660800)

  • 1. A Hitchhiker's guide to HIV.
    Yan A; Ellington A
    Mol Ther; 2008 Aug; 16(8):1356-8. PubMed ID: 18660800
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.
    Zhou J; Li H; Li S; Zaia J; Rossi JJ
    Mol Ther; 2008 Aug; 16(8):1481-9. PubMed ID: 18461053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition.
    Zhou J; Shu Y; Guo P; Smith DD; Rossi JJ
    Methods; 2011 Jun; 54(2):284-94. PubMed ID: 21256218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery.
    Zhou J; Li H; Zhang J; Piotr S; Rossi J
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-targeted RNAi for HIV-1 therapy.
    Zhou J; Rossi JJ
    Methods Mol Biol; 2011; 721():355-71. PubMed ID: 21431697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge.
    Zhou J; Neff CP; Swiderski P; Li H; Smith DD; Aboellail T; Remling-Mulder L; Akkina R; Rossi JJ
    Mol Ther; 2013 Jan; 21(1):192-200. PubMed ID: 23164935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction of a eukaryotic expression plasmid containing gp120 gene of HIV-1 subtype B and its expression in HepG2 cells].
    Li DL; Ma WL; Shi YX; Li L; Zhang B; Zheng WL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1724-7. PubMed ID: 17259106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.
    Zhou J; Rossi JJ; Shum KT
    Methods Mol Biol; 2015; 1297():169-85. PubMed ID: 25896003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All in the RNA family.
    Davidson BL
    Nat Biotechnol; 2006 Aug; 24(8):951-2. PubMed ID: 16900139
    [No Abstract]   [Full Text] [Related]  

  • 10. Aptamer-siRNA chimeras for HIV.
    Takahashi M; Burnett JC; Rossi JJ
    Adv Exp Med Biol; 2015; 848():211-34. PubMed ID: 25757623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anti-HIV aptamers based on tetra-end-linked DNA G-quadruplexes: effect of the base sequence on anti-HIV activity.
    D'Atri V; Oliviero G; Amato J; Borbone N; D'Errico S; Mayol L; Piccialli V; Haider S; Hoorelbeke B; Balzarini J; Piccialli G
    Chem Commun (Camb); 2012 Oct; 48(76):9516-8. PubMed ID: 22898884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular delivery of RNA-based therapeutics using aptamers.
    Thiel KW; Giangrande PH
    Ther Deliv; 2010 Dec; 1(6):849-61. PubMed ID: 21643487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Envelope glycoprotein 120 sequences of primary HIV type 1 isolates from Pune and New Delhi, India.
    Tripathy S; Renjifo B; Wang WK; McLane MF; Bollinger R; Rodrigues J; Osterman J; Tripathy S; Essex M
    AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1199-202. PubMed ID: 8844026
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapies for HIV with RNAi.
    Nekhai S; Jerebtsova M
    Curr Opin Mol Ther; 2006 Feb; 8(1):52-61. PubMed ID: 16506526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.
    Abdel-Motal U; Wang S; Lu S; Wigglesworth K; Galili U
    J Virol; 2006 Jul; 80(14):6943-51. PubMed ID: 16809300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential change of cysteine residues in hypervariable region 1 of glycoprotein 120 in primary HIV type 1 isolates of subtype B.
    Wang WK; Mayer KH; Essex M; Lee TH
    AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1195-7. PubMed ID: 8844025
    [No Abstract]   [Full Text] [Related]  

  • 17. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
    ter Brake O; Konstantinova P; Ceylan M; Berkhout B
    Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions.
    McFadden K; Cocklin S; Gopi H; Baxter S; Ajith S; Mahmood N; Shattock R; Chaiken I
    Proteins; 2007 May; 67(3):617-29. PubMed ID: 17348010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1.
    Dey AK; Griffiths C; Lea SM; James W
    RNA; 2005 Jun; 11(6):873-84. PubMed ID: 15923374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.